EBNA-1 specific effector T cell deletion associated with holoendemic malaria exposure in the etiology of endemic Burkitt’s lymphoma (P3063)
dc.contributor.author | Mulama, David | |
dc.contributor.author | Chelimo, Kiprotich | |
dc.contributor.author | Collins, Ouma | |
dc.contributor.author | Jura, Walter | |
dc.contributor.author | Otieno, Juliana | |
dc.contributor.author | Vulule, John | |
dc.contributor.author | Munz, Christian | |
dc.contributor.author | Moormann, Ann | |
dc.date.accessioned | 2018-01-23T09:36:01Z | |
dc.date.available | 2018-01-23T09:36:01Z | |
dc.date.issued | 2013-05-01 | |
dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/188 | |
dc.description.abstract | Etiological mechanism of eBL remain largely unknown despite long-standing epidemiological link between malaria and EBV co-infection. Age-dependent deficiency in EBV-specific CD8+ T cell-mediated IFN-γ immunosurveillance has been reported in malaria holoendemic exposed children which has been associated with eBL diagnosis. We sought to investigate whether qualitative differences in EBNA-1 specific T cells existed in malaria- exposed children to explain their increased risk for eBL. We conducted a cross-sectional study of healthy children from western Kenya with divergent malaria exposure: Kisumu (holoendemic) and Nandi (hypoendemic) and eBL age-matched patients. T cell effector function was evaluated by multiparameter flow cytometry against T cell lineage markers (CD3, 4, 8, 45RA & CCR7) and functional phenotype (IFN-γ, IL10, IL17 & PD1) to EBNA-1 … | en_US |
dc.publisher | American Association of Immunologists | en_US |
dc.title | EBNA-1 specific effector T cell deletion associated with holoendemic malaria exposure in the etiology of endemic Burkitt’s lymphoma (P3063) | en_US |
dc.type | Article | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |